Dawn Christine Maroney Sells 16,535 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $16.40, for a total value of $271,174.00. Following the transaction, the president now owns 2,374,051 shares of the company's stock, valued at $38,934,436.40. This trade represents a 0.69 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Performance

Shares of NASDAQ ALHC traded down $0.15 during midday trading on Monday, hitting $17.46. The company's stock had a trading volume of 1,682,034 shares, compared to its average volume of 1,429,451. The stock has a fifty day moving average price of $14.98 and a 200 day moving average price of $12.78. The firm has a market capitalization of $3.35 billion, a price-to-earnings ratio of -22.68 and a beta of 1.49. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $18.34. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. JPMorgan Chase & Co. upped their target price on Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Bank of America boosted their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a research report on Tuesday, March 4th. Stifel Nicolaus raised their target price on Alignment Healthcare from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, February 28th. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. Finally, Piper Sandler increased their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a research report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $14.83.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors have recently made changes to their positions in the stock. Wellington Management Group LLP grew its position in shares of Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock valued at $83,683,000 after purchasing an additional 3,257,630 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Alignment Healthcare by 54.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock valued at $97,302,000 after buying an additional 3,059,596 shares in the last quarter. Millennium Management LLC increased its position in shares of Alignment Healthcare by 588.3% during the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after buying an additional 2,896,311 shares during the period. Point72 Asset Management L.P. purchased a new stake in shares of Alignment Healthcare in the fourth quarter worth about $20,087,000. Finally, Broad Bay Capital Management LP bought a new position in shares of Alignment Healthcare in the fourth quarter valued at approximately $18,804,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.